A biosimilar boost amid trade barriers
Even as India’s biggest pharma companies pursue biosimilars, product recalls related to manufacturing defects threaten to queer…
Author
Direct-to-Retail will increasingly complement traditional pharma distribution
Aqualab has crossed Rs 100 crore in just three years, what have been the key drivers behind this growth, and how does the brand…
We can help our customers reach markets faster
Excerpts from the interview:
What’s the vision and strategy behind Merck's Formulation & Technology Center in Navi Mumbai,…
Will India pass the cough syrup trust test this time?
While India’s CDMOs are well positioned to capitalise on the booming GLP-1 market, the recurring episodes of contaminated cough…
Turning the tariff tight spot into a sweet spot
US President Trump's fresh salvo of 100 per cent tariffs on branded or patented pharmaceutical products not ‘Made in America’…
Tariff turbulence sparks a reset
India’s pharma sector is rewriting its global playbook pivoting to other markets like the EU, Africa and other geographies with…
Walking the talk on ESG, workplace safety
Proactively investing in employee and workplace safety is not just good for employees, but makes smart business sense
The promise and perils of weight loss drugs
Doctors have warned of the risk of overuse and misuse, cautioning that patients will see such medications as an easy, quick fix,…
India needs to step up more as a strategic innovator in the global supply chain
In a free wheeling conversation, US-based Hari Kiran Chereddi, MD, HRV Global Life Sciences explains to Viveka Roychowdhury that…
We are well-aligned to capitalise on the CDMO opportunity
Dr Abdelaziz Toumi, CEO, Lupin Manufacturing Solutions (LMS), explains to Viveka Roychowdhury how LMS is aligning long-term…